Announcements Trials
Browse Landscape

Phase

Phase NA 57Phase 2 39Phase 3 29Phase 1 27Phase 1/2 13Phase 2/3 5Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 10Prostatic Neoplasms 6Multiple Myeloma 6Neoplasms 3Hematologic Neoplasms 3Carcinoma, Hepatocellular 3Papillomavirus Infections 2Neoplasm Metastasis 2Melanoma 2Leukemia, Myeloid, Acute 2Venous Thromboembolism 1Tumor Lysis Syndrome 1Thyroid Neoplasms 1Thyroid Diseases 1Thalassemia 1Squamous Cell Carcinoma of Head and Neck 1Skin Substitutes 1Skin Neoplasms 1Pulmonary Embolism 1Primary Myelofibrosis 1Post-operative Seroma Formation 1Polycythemia Vera 1Parathyroid Diseases 1Overweight 1Osteoradionecrosis 1Opioid-Related Disorders 1Oligodendroglioma 1Obesity 1Neutropenia 1Neurofibromatosis 1 1

Interventions

Specimen Handling 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lung Neoplasms × 30 days × Clear all
NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

OHSU Knight Cancer Institute

Phase 4 Recruiting
160 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡